This Week at FDA: Conflict of interest questions threaten to cloud Shuren’s legacy, FDA signs off on updated COVID vaccines

This Week at FDA

This Week at FDAFerdous Al-Faruque

Approval/marketing authorizationDiagnostics/IVDsGuidanceMedical DevicesPharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)